| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Department of Pathology, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania; and Mt. Desert Island Biological Laboratory, Salisbury Cove, Maine)
Experiments were done to determine whether the effect of steroids in increasing metastases could be correlated with their glucocorticoid or mineralocorticoid activity. 6
, 9
-difluoroprednisolone (DFP), cortisone, and deoxycorticosterone (DOC) were tested for effects on metastases produced by intravenous injection of B16 tumor cells in C57/BL6 mice.
Appropriate doses and times of administration were first determined. The maximum steroid effect on metastases appeared in those mice receiving 0.5 mg. of steroid 48 hours before the injection of tumor cells. Glucocorticoid activity was also assayed. Both DFP and cortisone increased metastases. DFP was more effective in increasing metastases than was cortisone, and DFP revealed more glucocorticoid activity. DOC did not increase metastases and displayed no glucocorticoid activity. A large dose of DFP did not increase metastases as much as a smaller dose, and the larger dose had less glucocorticoid activity. It is concluded that the capacity of a steroid to increase metastases is correlated with its glucocorticoid activity.
* This investigation was supported by Grants C-2356 and CRT-5022 from the Division of Research Grants and Fellowships of the National Institutes of Health, United States Public Health Service.
Received 6/ 6/62.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |